OBJECTIVES The aim of this study was to review randomized controlled trials (RCTs) using cardiac magnetic resonance (CMR) to assess myocardial infarct (MI) size in reperfused patients with ST-segment elevation myocardial infarction (STEMI).
Late gadolinium enhancement (LGE) by CMR is considered the gold standard for MI size quantification (4). MI size (5), microvascular obstruction (MVO) (6) , and myocardial salvage (7) assessed by CMR performed in the first few days post-PPCI have all been
shown to be strongly prognostic. As a result, CMR is increasingly being used for surrogate endpoints in RCTs (3). A recent meta-analysis of 2,632 patients from 10 RCTs found that MI size measured by CMR or singlephoton computed tomography within 1 month post-PPCI showed that for every 5% increase in MI size, there was a 20% increase in the relative hazard ratio for 1-year hospitalization for heart failure and all-cause mortality (5).
Despite CMR endpoints being quite robust and their ability to keep sample size small (3), there is limited guidance on its use. In this study, we reviewed all published RCTs in this field so far, and we provide recommendations for standardizing the use of CMR in future clinical cardioprotection RCTs.
METHODS
We performed a comprehensive systematic search in the MEDLINE and Embase databases via Ovid up to The expected sample sizes were provided for each group after accounting for potential dropouts. [53%]), as shown in Figure 3 .
RESULTS

Our
Forty-six of the RCTs (74%) used 1.5-T scanners, and a minority (2 RCTs [3%]) used 3-T scanners.
Four RCTs (7%) used a combination of 1.5-and 3-T scanners. Ten RCTs (16%) did not specify the field were multicenter RCTs. Online Table 2 Bulluck et al. center RCTs. Figure 5 shows the distribution of the quantification techniques for MI size used in these RCTs.
DISTRIBUTION OF CULPRIT VESSEL AND TIMI FLOW
PRE-PPCI. Among the RCTs including all culprit vessels (n ¼ 6,020), 45% of the patients had STEMI in the left anterior descending coronary artery territory.
Among the RCTs including all TIMI flow grades (n ¼ 3,229), 73% of patients had TIMI flow grades of 0 or 1 pre-PPCI.
EFFECT SIZE FOR REDUCTION IN MI SIZE IN RCTs
WITH POSITIVE RESULTS. Seventeen RCTs were positive for a reduction in MI size. Of the RCTs reporting MI size as %LV, the median reduction in acute MI size was 34% (mode 35%; range 14% to 38%).
As for chronic MI size, both the median and mode reduction in MI size were 18% (range 14% to 46%). DROPOUT RATES. In RCTs using CMR for the primary endpoint, the average dropout rate was 9% for RCTs using acute CMR only, 13% for RCTs acquiring followup CMR only, and 16% for those with paired acute and follow-up scans.
DISCUSSION
On the basis of the 62 RCTs reviewed, substantial heterogeneity exists in trial design with respect to patient selection, timing of acute and follow-up scans, GBCA dose, timing of LGE acquisition, and method for MI quantification. Among those RCTs not reporting scanner strength and vendor, GBCA used, and software used for MI size quantification, the majority were multicenter RCTs.
The other major findings were as follows: 1) acute CMR was most commonly performed at 3 to 5 days and follow-up CMR at 6 months; 2) Gd-DOTA, gadobutrol, and Gd-DTPA were most commonly used at a similar dose of 0.20 mmol/kg, with LGE acquired at 10 min;
3) MI size was quantified manually in most RCTs, There was a wide range of timings for both scans, and the most common timings were 3 to 5 days for the acute scan and 6 months for the follow-up scan. Bulluck et al. (27) . In the clinical setting, acute MI size has also been shown to be dynamic and to decrease significantly in size between days 1 and 7 (28, 29) but is stable between days 3 and 4 (8).
Recently, Carrick et al. (30) showed that acute MI size was stable between days 1 and 3 and subsequently reduced in size by day 10. Furthermore, late MVO has also been shown to be stable between days 1 and 3
and to reduce in size by day 10 (20) , and the persistence of late MVO at 1 week following STEMI was more prognostic (31) . The detection of intramyocardial hemorrhage has been shown to peak at day 3, and reduced in size and incidence by day 10, and intramyocardial hemorrhage was more prognostic than MVO (20) .
There is no established method to assess the AAR Acquiring LGE too early (<8 min) post-GBCA administration has been shown to result in overestimation of MI size (37) , and acquiring LGE at 25 min for acute MI size was a better predictor of LV recovery (38) . In most RCTs included in this study,
LGE imaging was performed at 10 min. Performing comprehensive CMR in patients with STEMI can be Although FWHM has emerged as being the most reproducible (39, 40) , it has been shown to underestimate acute and chronic MI size (40) . Some studies showed that 5-SD was promising (39-41), but others The references for the RCTs included in each row are provided in Online Table 5 .
CI ¼ confidence interval; CMR ¼ cardiac magnetic resonance; MI ¼ myocardial infarction; %LV ¼ percentage of left ventricular mass or volume; PPCI ¼ primary percutaneous coronary intervention; RCT ¼ randomized controlled trial; TIMI ¼ Thrombolysis in Myocardial Infarction.
showed that it overestimated MI size (42, 43) . The n-SD technique requires the remote myocardium to be appropriately nulled and free of artifacts. A manual region of interest is required in the remote myocardium, and this can be a source of variability.
The Otsu technique does not require a region of interest as a reference and has been shown to accurately delineate MI size (40) . But 2 subsequent studies showed that Otsu overestimated MI size (42, 43) .
The most common method used to quantify MI size in the RCTs was manual contouring, followed by 5-SD and FWHM. We recently showed that FWHM underestimates chronic MI size in those with MVO on the acute scan because of very high extracellular volume in the area previously occupied by MVO and should be avoided for RCTs assessing chronic MI size (42).
The 6-SD method appears the most promising and has been shown to have the highest accuracy to predict segment wall recovery in patients with chronic myocardial infarction (44) and is similar to manual quantification in patients with both acute and chronic myocardial infarction (39, 42) . The 6-SD approach also performed well when using 2 different LGE sequences (42) .
IMPACT OF PATIENT SELECTION AND TIMING OF
CMR ON SAMPLE SIZE. In Table 1 we provide guidance for expected sample sizes, depending on the Acute CMR should ideally be performed on day 3, 4, or 5. When a follow-up scan is planned, 6 months would be the optimal timing for data on both chronic MI size and LV remodeling.
The preferred GBCA should be gadobutrol (superior contrast-to-noise ratio) (35) at 0.15 mmol/kg (recommended relaxivity-adjusted standard dose) (35, 36) , with LGE performed at 15 min.
Manual quantification of MI size by experienced operators at a core laboratory level is considered the gold standard (4). When this is not practical, the 6-SD threshold would be an alternative option. However, any semiautomated technique is likely to be influenced by the LGE image quality, and therefore, each LGE ¼ late gadolinium enhancement; PPCI ¼ primary percutaneous coronary intervention.
center may need to validate the performance of these semiautomated techniques at the respective center or core laboratory.
In the absence of a gold-standard method for the AAR, MI size should be reported as %LV, which has also been shown to be prognostic (5 hausenloy@duke-nus.edu.sg. 
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